<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36046683</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-0994</ISSN><JournalIssue CitedMedium="Internet"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Oxidative medicine and cellular longevity</Title><ISOAbbreviation>Oxid Med Cell Longev</ISOAbbreviation></Journal><ArticleTitle>Autophagy-Mediated Inflammatory Cytokine Secretion in Sporadic ALS Patient iPSC-Derived Astrocytes.</ArticleTitle><Pagination><StartPage>6483582</StartPage><MedlinePgn>6483582</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6483582</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2022/6483582</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Astrocytes can be involved in motor neuron toxicity in amyotrophic lateral sclerosis (ALS) induced by noncell autonomous effects, and inflammatory cytokines may play the main role in mediating this process. However, the etiology of aberrant cytokine secretion is unclear. The present study assessed possible involvement of the mTOR-autophagy pathway in aberrant cytokine secretion by ALS patient iPSC-derived astrocytes. <i>Method and Results</i>. PBMCs from sporadic ALS patients and control subjects were reprogrammed into iPSCs, which were then differentiated into astrocytes and/or motor neurons. Comparison with control astrocytes indicated that conditioned medium of ALS astrocytes reduced the viability of the control motor neurons (<i>p</i> &lt; 0.05) assessed using the MTT assay. The results of ELISA showed that the concentrations of TNF<i>&#x3b1;</i>, IL1<i>&#x3b2;</i>, and IL6 in cell culture medium of ALS astrocytes were increased (<i>p</i> &lt; 0.05). ALS astrocytes had higher p62 and mTOR levels and lower LC3BII/LC3BI ratio and ULK1 and p-Beclin-1 (Ser15) levels (<i>p</i> &lt; 0.05), indicating defective autophagy. Exogenous inhibition of the mTOR-autophagy pathway, but not the activation of the pathway in control subject astrocytes, increased the levels of p62 and mTOR and concentration of IL-1<i>&#x3b2;</i>, TNF-<i>&#x3b1;</i>, and IL-6 in cell culture medium and decreased the LC3BII/LC3BI ratio and levels of ULK1 and p-Beclin-1 (Ser15), and these changes were comparable to those in ALS astrocytes. After 48&#x2009;h of rapamycin (autophagy activator) and 3-methyladenine (autophagy inhibitor) treatments, the exogenous activation of the mTOR-autophagy pathway, but not inhibition of the pathway, in ALS astrocytes significantly reduced the concentrations of TNF<i>&#x3b1;</i>, IL1<i>&#x3b2;</i>, and IL6 in cell culture medium and reduced the levels of p62, while increasing the levels of LC3B-II/LC3B-I, ULK1, and p-Beclin-1 (Ser15), and these changes were comparable to those in control subject astrocytes.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Alteration in the mTOR/ULK1/Beclin-1 pathway regulated cytokine secretion in ALS astrocytes, which was able to lead to noncell autonomous toxicity. Autophagy activation mitigated cytokine secretion by ALS astrocytes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 BaofengFeng et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>BaofengFeng</LastName><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Anatomy Department, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amponsah</LastName><ForeName>Asiamah Ernest</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Ruiyun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jinyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Xiaofeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zijing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2843-0769</Identifier><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Anatomy Department, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Huixian</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hebei Medical University-National University of Ireland Galway Stem Cell Research Center, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province 050017, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Anatomy Department, Hebei Medical University, Hebei Province 050017, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oxid Med Cell Longev</MedlineTA><NlmUniqueID>101479826</NlmUniqueID><ISSNLinking>1942-0994</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071186">Beclin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071186" MajorTopicYN="N">Beclin-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>All authors declare no conflict of interest regarding the present work, and they have no involvements that might raise the question of bias in the work reported or in the conclusions, implications, or opinions stated.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>1</Day><Hour>2</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36046683</ArticleId><ArticleId IdType="pmc">PMC9423978</ArticleId><ArticleId IdType="doi">10.1155/2022/6483582</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu J., Wang F. Role of Neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Frontiers in Immunology . 2017;8:p. 1005. doi: 10.3389/fimmu.2017.01005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01005</ArticleId><ArticleId IdType="pmc">PMC5567007</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: a clinical review. European Journal of Neurology . 2020;27(10):1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A. M., Hester M. E., Miranda C. J., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nature Biotechnology . 2011;29(9):824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K., Ferraiuolo L., Miranda C. J., et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proceedings of the National Academy of Sciences . 2014;111(2):829&#x2013;832. doi: 10.1073/pnas.1314085111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314085111</ArticleId><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K., Huang H., Peterson A., et al. Sporadic ALS astrocytes induce neuronal degeneration in vivo. Stem Cell Reports . 2017;8(4):843&#x2013;855. doi: 10.1016/j.stemcr.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto M. C. N., Muotri A. R., Mu Y., Smith A. M., Cezar G. G., Gage F. H. Non-cell-autonomous effect of human SOD1G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell . 2008;3(6):649&#x2013;657. doi: 10.1016/j.stem.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.10.001</ArticleId><ArticleId IdType="pubmed">19041781</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A., Ben-Dor I., Ottolenghi M., et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. eBioMedicine . 2019;50:274&#x2013;289. doi: 10.1016/j.ebiom.2019.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.026</ArticleId><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Granatiero V., Sayles N. M., Savino A. M., et al. Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1G93Aastrocytes. Autophagy . 2021;17(12):4029&#x2013;4042. doi: 10.1080/15548627.2021.1899682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1899682</ArticleId><ArticleId IdType="pmc">PMC8726657</ArticleId><ArticleId IdType="pubmed">33749521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A., McAvoy K., Krishnamurthy K., Trotti D., Pasinelli P. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia . 2018;66(5):1016&#x2013;1033. doi: 10.1002/glia.23298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Varcianna A., Myszczynska M. A., Castelli L. M., et al. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS. eBioMedicine . 2019;40:626&#x2013;635. doi: 10.1016/j.ebiom.2018.11.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.11.067</ArticleId><ArticleId IdType="pmc">PMC6413467</ArticleId><ArticleId IdType="pubmed">30711519</ArticleId></ArticleIdList></Reference><Reference><Citation>Berjaoui S., Povedano M., Garcia-Esparcia P., Carmona M., Aso E., Ferrer I. Complex inflammation mRNA-related response in ALS is region dependent. Neural Plasticity . 2015;2015:11. doi: 10.1155/2015/573784.573784</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/573784</ArticleId><ArticleId IdType="pmc">PMC4537753</ArticleId><ArticleId IdType="pubmed">26301107</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Cao C., Qin X. Y., et al. Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Scientific Reports . 2017;7(1):p. 9094. doi: 10.1038/s41598-017-09097-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09097-1</ArticleId><ArticleId IdType="pmc">PMC5567306</ArticleId><ArticleId IdType="pubmed">28831083</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q., Huo Y., Bai J., et al. Inflammatory cytokine levels in patients with sporadic amyotrophic lateral sclerosis. Neuro-Degenerative Diseases . 2021;21:87&#x2013;92. doi: 10.1159/000522078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522078</ArticleId><ArticleId IdType="pubmed">35124669</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortelli R., Zecca C., Piccininni M., et al. Plasma inflammatory cytokines are elevated in ALS. Frontiers in Neurology . 2020;11, article 552295 doi: 10.3389/fneur.2020.552295.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.552295</ArticleId><ArticleId IdType="pmc">PMC7691268</ArticleId><ArticleId IdType="pubmed">33281700</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Li J., Zheng J., Qin S. Reactive astrocytes in neurodegenerative diseases. Aging and Disease . 2019;10(3):664&#x2013;675. doi: 10.14336/AD.2018.0720.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2018.0720</ArticleId><ArticleId IdType="pmc">PMC6538217</ArticleId><ArticleId IdType="pubmed">31165009</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wagoner N. J., Oh J. W., Repovic P., Benveniste E. N. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. The Journal of Neuroscience . 1999;19(13):5236&#x2013;5244. doi: 10.1523/JNEUROSCI.19-13-05236.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-13-05236.1999</ArticleId><ArticleId IdType="pmc">PMC6782316</ArticleId><ArticleId IdType="pubmed">10377335</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian M., Fang X., Wang X. Autophagy and inflammation. Clinical and Translational Medicine . 2017;6(1):p. 24. doi: 10.1186/s40169-017-0154-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40169-017-0154-5</ArticleId><ArticleId IdType="pmc">PMC5529308</ArticleId><ArticleId IdType="pubmed">28748360</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J. N., Fattah E. A., Bhattacharya A., Ko S., Eissa N. T. Inflammasome activation by altered proteostasis. The Journal of Biological Chemistry . 2013;288(50):35886&#x2013;35895. doi: 10.1074/jbc.M113.514919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.514919</ArticleId><ArticleId IdType="pmc">PMC3861638</ArticleId><ArticleId IdType="pubmed">24178293</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonninen T. M., Goldsteins G., Laham-Karam N., Koistinaho J., Lehtonen S. Proteostasis disturbances and inflammation in neurodegenerative diseases. Cell . 2020;9(10):p. 2183. doi: 10.3390/cells9102183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9102183</ArticleId><ArticleId IdType="pmc">PMC7601929</ArticleId><ArticleId IdType="pubmed">32998318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T. T., Li W. M., Yao Y. M. Interactions between autophagy and inhibitory cytokines. International Journal of Biological Sciences . 2016;12(7):884&#x2013;897. doi: 10.7150/ijbs.15194.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.15194</ArticleId><ArticleId IdType="pmc">PMC4910606</ArticleId><ArticleId IdType="pubmed">27313501</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N., Pandey U. B. Autophagy dysregulation in ALS: when protein aggregates get out of hand. Frontiers in Molecular Neuroscience . 2017;10:p. 263. doi: 10.3389/fnmol.2017.00263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00263</ArticleId><ArticleId IdType="pmc">PMC5572252</ArticleId><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S., King A., Troakes C., et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathologica . 2011;122(6):691&#x2013;702. doi: 10.1007/s00401-011-0911-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0911-2</ArticleId><ArticleId IdType="pubmed">22101323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiji M., Takahashi T., Fukuba H., Yamashita H., Kohriyama T., Matsumoto M. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin. Acta Neuropathologica . 2008;116(2):183&#x2013;191. doi: 10.1007/s00401-008-0402-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0402-2</ArticleId><ArticleId IdType="pubmed">18584184</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E. L., Vance C., Nishimura A. L., et al. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. Journal of Cell Science . 2014;127, Part 6:1263&#x2013;1278. doi: 10.1242/jcs.140087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.140087</ArticleId><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J., Feng B., Kong D., et al. Production and validation of human induced pluripotent stem cell line from sporadic amyotrophic lateral sclerosis (SALS) Stem Cell Research . 2020;44, article 101760 doi: 10.1016/j.scr.2020.101760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2020.101760</ArticleId><ArticleId IdType="pubmed">32203916</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo R., Liu X., Zhang J., et al. Integration-free induced pluripotent stem cell line derived from a 62-years-old male donor with APOE-epsilon4/epsilon4 alleles. Stem Cell Research . 2022;61, article 102746 doi: 10.1016/j.scr.2022.102746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2022.102746</ArticleId><ArticleId IdType="pubmed">35305470</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z.-W., Chen H., Liu H., et al. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nature Communications . 2015;6(1):p. 6626. doi: 10.1038/ncomms7626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7626</ArticleId><ArticleId IdType="pmc">PMC4375778</ArticleId><ArticleId IdType="pubmed">25806427</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R., Montagnani Marelli M., Cicardi M. E., et al. Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells. Cell Death &amp; Disease . 2018;9(9):p. 889. doi: 10.1038/s41419-018-0866-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0866-5</ArticleId><ArticleId IdType="pmc">PMC6117300</ArticleId><ArticleId IdType="pubmed">30166521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou H., Zhang Y., Huang Y., et al. Inhibitors of phosphatidylinositol 3'-kinases promote mitotic cell death in HeLa cells. PLoS One . 2012;7(4, article e35665) doi: 10.1371/journal.pone.0035665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035665</ArticleId><ArticleId IdType="pmc">PMC3335795</ArticleId><ArticleId IdType="pubmed">22545128</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S.-H., Park E., You B., et al. Neuronal synapse formation induced by microglia and interleukin 10. PLoS One . 2013;8(11, article e81218) doi: 10.1371/journal.pone.0081218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081218</ArticleId><ArticleId IdType="pmc">PMC3838367</ArticleId><ArticleId IdType="pubmed">24278397</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohl S. G., Schmeer C. W., Friese T., Witte O. W., Isenmann S. In situ dividing and phagocytosing retinal microglia express nestin, vimentin, and NG2 in vivo. PLoS One . 2011;6(8, article e22408) doi: 10.1371/journal.pone.0022408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022408</ArticleId><ArticleId IdType="pmc">PMC3151247</ArticleId><ArticleId IdType="pubmed">21850226</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang R., Zeh H. J., Lotze M. T., Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death and Differentiation . 2011;18(4):571&#x2013;580. doi: 10.1038/cdd.2010.191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2010.191</ArticleId><ArticleId IdType="pmc">PMC3131912</ArticleId><ArticleId IdType="pubmed">21311563</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F. P., Boulting G. L., Bobrowicz S., Eggan K. C. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell . 2008;3(6):637&#x2013;648. doi: 10.1016/j.stem.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.09.017</ArticleId><ArticleId IdType="pubmed">19041780</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D., La Salvia S., Giannini M., et al. Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients. Frontiers in Neuroscience . 2018;12:p. 487. doi: 10.3389/fnins.2018.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00487</ArticleId><ArticleId IdType="pmc">PMC6060258</ArticleId><ArticleId IdType="pubmed">30072868</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Gao W. Effects of TNF-&#x3b1; on autophagy of rheumatoid arthritis fibroblast-like synoviocytes and regulation of the NF-&#x3ba;B signaling pathway. Immunobiology . 2021;226(2, article 152059) doi: 10.1016/j.imbio.2021.152059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2021.152059</ArticleId><ArticleId IdType="pubmed">33561598</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y., Ding D., Zhang N., et al. TNF-&#x3b1; induces autophagy through ERK1/2 pathway to regulate apoptosis in neonatal necrotizing enterocolitis model cells IEC-6. Cell Cycle . 2018;17(11):1390&#x2013;1402. doi: 10.1080/15384101.2018.1482150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2018.1482150</ArticleId><ArticleId IdType="pmc">PMC6110600</ArticleId><ArticleId IdType="pubmed">29950141</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F., Song D., Yan Y., et al. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nature Communications . 2021;12(1):p. 3651. doi: 10.1038/s41467-021-23923-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23923-1</ArticleId><ArticleId IdType="pmc">PMC8206314</ArticleId><ArticleId IdType="pubmed">34131122</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin B., Zhou Z., He J., Yan C., Ding S. IL-6 inhibits starvation-induced autophagy via the STAT3/Bcl-2 signaling pathway. Scientific Reports . 2015;5(1, article 15701) doi: 10.1038/srep15701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15701</ArticleId><ArticleId IdType="pmc">PMC4637890</ArticleId><ArticleId IdType="pubmed">26549519</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>